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Abstract
Brucellosis is a common zoonotic disease that remains endemic in many parts of the world. Dissecting the host immune
response during this disease provides insight as to why brucellosis is often difficult to resolve. We used a Brucella epitope
specific in vivo killing assay to investigate the ability of CD8+ T cells to kill targets treated with purified pathogenic protein.
Importantly, we found the pathogenic protein TcpB to be a novel effector of adaptive immune evasion by inhibiting CD8+ T
cell killing of Brucella epitope specific target cells in mice. Further, BALB/c mice show active Brucella melitensis infection
beyond one year, many with previously unreported focal infection of the urogenital area. A fraction of CD8+ T cells show a
CD8+ Tmem phenotype of LFA-1hi, CD127hi, KLRG-1lo during the course of chronic brucellosis, while the CD8+ T cell pool
as a whole had a very weak polyfunctional cytokine response with diminished co-expression of IFN-c with TNFa and/or IL-2,
a hallmark of exhaustion. When investigating the expression of these 3 cytokines individually, we observed significant IFN-c
expression at 90 and 180 days post-infection. TNFa expression did not significantly exceed or fall below background levels
at any time. IL-2 expression did not significantly exceeded background, but, interestingly, did fall significantly below that of
uninfected mice at 180 days post-infection. Brucella melitensis evades and blunts adaptive immunity during acute infection
and our findings provide potential mechanisms for the deficit observed in responding CD8+ T cells during chronic
brucellosis.
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Introduction
Brucella spp. are the cause of the most common zoonotic disease
in man. There are approximately 500,000 new cases diagnosed
each year, with endemic disease flourishing in the Middle East,
Mediterranean basin, Northern Africa, and across the Asian
continent. Human brucellosis is grossly under diagnosed as its
symptoms are frequently similar to influenza and malaria, among
others (i.e., fever, fatigue, headaches, general malaise, and
myalgia) [1]. Vaccine development has continued for decades
with limited success [2,3,4]. Recent advances in immunological
methods and technology have made it possible to dissect the
correlates of protective immunity in brucellosis, bringing much
needed hope to the collective vaccine effort.
The immune response to Brucella infection is extremely varied
and depends on the host, species or strain of Brucella, and
environment. B. melitensis is a facultative, intracellular, and Gram-
negative bacteria that is not contained by innate immunity [5].
The antibody response can lower the level of initial infection by
the production of IgG opsonins but has little effect on the
intracellular phase of Brucella. Macrophages kill 90–95% of all
phagocytosed bacteria, which would appear to be a successful
innate response, yet once the surviving few reach their replicative
niche, successful infection of the host is all but guaranteed [6].
Over its extremely long history as a human pathogen, Brucella has
evolved some impressive and redundant mechanisms to evade
innate immunity [7,8]. These include blocking activation of NFk-
B by mimicking a host protein, producing a non-reactive LPS,
using phagosome acidification to its advantage, and inhibiting
phagosome-lysosome fusion [9,10,11,12,13,14]. These known
mechanisms along with additional unknown disruptors of the
adaptive immune response contribute to its low infectious dose
where 20 bacteria ensure an ID90 in humans [15]. There remain
many unknowns regarding the success or failure of the adaptive
cell mediated response during active or chronic brucellosis.
Although CD8+ T cells are considered critical to resolution of
intracellular bacterial infections, few details are known as to why
Brucella spp. persist in the presence of CD8+ T cells. Uncovering
more of the particulars of the CD8+ T cell mediated response, for
example specific surface phenotypes, factors produced, cellular
interactions, and cytotoxic T cell killing of cells expressing Brucella
peptides will provide needed insight for successful and safe vaccine
design [16,17,18].
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prevent its own exposure to immune surveillance [19]. Infection
with live Brucella leads to the prolonged life of host macrophages
which are protected from apoptosis [5,20,21,22]. Work in our lab
on a cell permeable protein of B. melitensis, TcpB, has shown its
targets to include multiple phosphatidylinositols, particularly those
involved at the immunological synapse on the target cell side
[13,14]. When phosphatidylinositol (4,5) bisphosphate (PI(4,5)P2)
is sequestered away from the synapse, the target cell is rendered
resilient against CD8+ T cell mediated killing [23]. The functional
capacity of CD8+ T cell effectors and the size of the memory pool
can be dependent upon early antigenic, costimulatory, and
inflammatory signals [17,18,24]. By inhibiting the killing of
infected cells in vivo in the presence of specific cytotoxic cells, B.
melitensis could effectively dampen the immune response, an insult
resulting in a smaller and ineffective long-lived memory pool.
There have been recent advances in the broad understanding of
CD8+ T cell memory (CD8+ Tmem), recall responses, and
exhaustion [25,26,27,28,29,30]. CD8+ Tmem cells exhibit stem
cell like properties for example longevity, telomerase expression,
self-renewal, and a multipotent state that is poised for activation
[31]. Also, proliferative capacity of long-lived CD8+ T cells
correlates with long-term vaccine efficacy [32], and the recall
response mediated by these cells confers protection to a wide
variety of infections [33]. A pathogen that evades or disables this
response can successfully live long-term within the host, virtually
undisturbed. Exploiting the recall response to overcome patho-
genic insult via vaccine design may enable researchers to finally
protect against low-level reactivating chronic Brucella infection.
During acute infection T cells have tight control of cytokine
expression, with the ability for rapid on/off regulation [34].
Conversely, in chronic viral infection, T cells are present, but long-
lived CD8+ cells lose their ability to produce multiple inflamma-
tory cytokines in a stepwise manner as infection persists [35,36,37].
In-depth phenotyping and dissection of the multifunctional Th1
component of non-viral infections is underway, with recent work
done in Mycobacterium, Salmonella, and Leishmania, among others
[38,39,40]. This direction of investigation is crucial in under-
standing Brucella pathogenesis because functional cytokine exhaus-
tion can lead to reactivation of senescent disease with the loss of
immune control, as chronic presentation of antigen can induce
CD8+ T cell tolerance [24,37]. In human brucellosis, after intense
antibiotic treatment of acute infection, reactivation of disease
occurs unpredictably, even in otherwise healthy adults [41,42,43].
Brucellosis-acquired cellular anergy has long been noted; however,
the mechanism behind this phenomenon is not understood [44].
Here we address the extent of CD8+ T cell memory phenotype
and cytokine expression in the host response to chronic B. melitensis
infection. Our overarching hypothesis is a defect or deficit in the
quality of CD8+ T cell response to Brucella infection leads to a loss
of functional CD8+ T memory cells permitting long-term Brucella
survival.
Figure 1. The affect of TcpB on CD8+ T cell specific killing. A) Representative histogram of specific killing after an in vivo killing assay with
TcpB or maltose binding protein treatment of target cells. Epitope specific peak stained CFSE
hi is protected after TcpB treatment of target cells. B) The
percent specific killing determined after an overnight incubation of target cells with TcpB or maltose binding protein and then pulsed with Brucella
melitensis specific epitope. The X in each column on the x-axis indicates the presence of treatment, type of effectors, or target cells in each row.
***p,0.001, **p,0.01, *p,0.05.
doi:10.1371/journal.pone.0034925.g001
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possesses cell permeable properties, inhibits CD8+ T cell killing
of pathogen specific targets. This stunting of the early adaptive
response may play a role in the deficit seen in immunological
memory during chronic brucellosis. In brucellosis research,
BALB/c and C57BL/6 mice are considered prototypal susceptible
and resistant animal models, respectively, where the primary site
of infection is the spleen [6]. Here we show that the BALB/c
mouse model of brucellosis more closely mimics chronic human
infection than previously appreciated. We have unexpectedly
found that BALB/c mice do not clear the infection and in fact,
remain infected for more than 1 year. Surprisingly, B. melitensis can
be cultured from BALB/c spleens up to 9 months post-infection
and the CFUs show an undulation above and below the level of
detection over time. The Brucella responding CD8+ T cells lack
multiple cytokine production (polyfunctionality) while few cells
retain a surface memory phenotype in the face of chronic
infection. These CD8+T cell findings suggest an exhausted
phenotype that would promote long-term Brucella survival.
Results
TcpB is a novel effector of adaptive immune evasion by
Brucella melitensis
We have previously shown that B. melitensis TcpB suppresses
inflammatory cytokines of the host including TNF-a and IL-1b
[13,14]. There is recent evidence that targets of TcpB binding,
particularly the phosphoinositides, are involved in effector to
memory transition signaling in CD8+ T cells as well as involved at
the immunological synapse during directed CD8+ T cell killing of
target cells [23,27,28,45,46]. To investigate the involvement of
TcpB from B. melitensis in CD8+ T cell mediated killing, we
performed an in vivo killing assay as described [47]. Briefly, naı ¨ve
splenocytes were pulsed with the B. melitensis peptide
NGSSSMATV with TcpB or maltose binding protein as a control
and labeled with high Carboxyfluorescein succinimidyl ester
(CFSE) 5 mm [16]. Control splenocytes were pulsed with an
irrelevant peptide of GFP with our without TcpB and labeled with
a low amount of CFSE, 0.5 mm. Equal amounts of CFSE
hi and
CFSE
lo cells were combined and transferred (,1610
7 total cells/
mouse) via retroorbital injection to anaesthetized syngeneic mice
that had been peptide immunized 7 days prior. After 6 hrs spleens
were removed from the mice and examined by flow cytometry for
the expression of CFSE and compared to CFSE expression prior
to adoptive transfer.
Interestingly, cells treated with TcpB were significantly
protected from specific CD8+ T cell killing (Fig. 1A and B,
p,0.001). This observation supports our previous findings that a
deletion mutant of TcpB in B. melitensis produces a delay in mouse
infection as well as elevated TNFa and interleukin-1b in TcpB-
deficient Brucella compared to wild type bacteria [13]. This
suggests that TcpB is a novel effector of adaptive immune evasion
by an intracellular bacterial pathogen. By unknown mechanisms,
the ability of the pathogen to block responding CD8+ T cell killing
of specific targets may contribute to a long-term deficit in
immunological memory.
BALB/c mice remain persistently infected with virulent
Brucella melitensis
Mice (N=200), in groups of 4, were infected with biolumines-
cent B. melitensis and bacterial load of the spleen was evaluated
when mice were sacrificed at specific times post-infection (Fig. 2A).
The undulation of bacteria above and below the level of detection
over time suggests similarities to human brucellosis. Biolumines-
cent colonies continued to be cultured from the spleens of infected
mice 270 days post-infection demonstrating the chronic nature of
infection. No colonies were cultured from the spleens of uninfected
age-matched mice kept in separate micro-isolator cages at any
time during the experiments (data not shown).
Infected mice were also monitored for bacterial load prior to
death via biophotonic imaging (Fig. 2B). Uninfected age-matched
mice are shown on the right of each image. Bacterial luminescence
was detected at 450 days post-infection, though becoming barely
detectable at times, i.e. 150 days post-infection. Interestingly,
biophotonic imaging was more sensitive in detecting infection after
270 days post-infection than the classical method of culturing
bacteria from infected mice. Consistent with chronic human
reactivating brucellosis, ‘‘hotspots’’ of infection outside of the usual
bioluminescent urogenital location were observed in these mice
long after acute infections. Note the central chest infection at
270 days post-infection and abdominal infection at 350 days post-
infection.
The urogenital localization of bioluminescence was accompa-
nied in some cases by edema (Fig. 3A–B), redness, and/or
alopecia. The murine clitoral gland was consistent with the
anatomic luminescence (Fig. 3C, D, E, F). Microscopically, an
infiltration of mononuclear cells consistent with macrophages and
lymphocytes was observed in the lumen of the gland. Occasional
cells with pyknotic nuclei were present in the lining of the gland
(Fig. 3G, H, I). Further study is required to determine if the cells in
the gland or lumen contain bacteria.
CD8+ T cells with a memory phenotype are detectable in
chronically infected hosts
Because brucellosis remains in a chronic state in BALB/c mice,
the presence of a detectable CD8+ Tmem cell phenotype in these
mice was uncertain. To address this void in our understanding, a
combination of antibodies specific for CD3, CD8, LFA1, CD127,
and KLRG1 was used to interrogate splenocytes. These markers
can be used to distinguish naı ¨ve CD8+ T cells (LFA1
lo CD127
hi
KLRG1
lo), early effectors (LFA1
hi CD127
lo KLRG1
lo), short-lived
effectors (LFA1
hi CD127
lo KLRG1
hi), and CD8+ Tmem (LFA1
hi
CD127
hi KLRG1
lo) [48,49,50,51]. A distinct population of Tmem
cells was detected in the B. melitensis infected mice (Fig. 4A).
Analysis of the data revealed that infection with B. melitensis does
have a very significant impact on the presence of Tmem cells,
p,0.002 (Fig. 4B and C). Additionally, over time there was a
downward trend of Tmem cells in infected and age-matched
control mice that was significant, p,0.008 (Fig. 4C), most likely
reflecting an age-related decline in immune function of older mice.
Other controls included cells from infected and uninfected mice
pulsed with irrelevant peptide and cells pulsed with no peptide
(data not shown). The data were not significantly different from
the uninfected age-matched splenocyte data at any time point. In
summary, CD8+ Tmem are generated and maintained in mice with
chronic brucellosis at significantly higher levels than observed in
uninfected age-matched control mice.
CD8+ T cells are not highly functional during chronic
brucellosis
A measure of quality in CD8+ T cells responding to infection, is
the ability of a cell to simultaneously produce multiple cytokines
[52,53]. Multifunctional CD8+ T cells have not previously been
examined in Brucella infection. Here, we examined the ability of B.
melitensis responding CD8+ T cells to produce IFN-c in concert
with TNF-a and/or IL-2 (Fig. 5). Polyfunctional cells, producing 3
cytokines simultaneously, were near background values at all times
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PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e34925Figure 2. Persistence of infection. BALB/c mice were infected with 10
7 bioluminescent Brucella melitensis GR023. A) Colony forming units were
determined by culturing serial dilutions of lysed splenocytes for 3–5 days at 37uC. B) Images were captured with a ten minute exposure on an IVIS
Imaging System. The rainbow scale of luminescence for each image is in approximate photons. Age-matched control mice are shown in the
rightmost position of each individual photo. The day post infection when the images were collected is noted in the bottom right corner of each
frame.
doi:10.1371/journal.pone.0034925.g002
CTL Evasion, Low Quality CD8+ T Cells
PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e34925Figure 3. Infection localization. A) Mice infected with bioluminescent B. melitensis GR023 shown after luminescence imaging. B) The same image
as (A) with the bioluminescence removed to show edema in the urogenital area. The uninfected mouse is on the right side of the frame. A close up of
the infected mouse with edema and the control mouse are shown. Mice infected for 450 days are shown with C) bioluminescence, D) with
bioluminescence removed, E) just prior to dissection of urogenital area, and F) after dissection showing the clitoral gland (c) just subcutaneous of the
ureter (u). Female BALB/c mice infected for 240 days at 206magnification with infiltration of neutrophils, lymphocytes and macrophages shown by
arrows in the G) interstitial region of the clitoral gland, H) lumen of the mammary glands, and I) perivascular cuffing in the subcutaneous tissue of the
perianal area.
doi:10.1371/journal.pone.0034925.g003
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significant, p,0.06 (Fig. 5A). Dual function cells, either IFN-c
together with TNF-a or IFN-c together with IL-2, also did not
significantly exceed background at any time examined (Fig. 5B
and C, p,0.7 and ,0.8, respectively) supporting a lack of cytokine
function by CD8+ T cells. It remains to be determined whether
these cells lose function over time or never establish polyfunction-
ality during brucellosis.
IFN-c expression of CD8+ T cells undulates in chronic
brucellosis, while TNF-aa and IL-2 are not expressed
significantly above background levels at any time
examined
To further investigate the cytokine production of CD8+ T cells
during chronic brucellosis, we examined the expression of IFN-c,
TNF-a, and IL-2 independently of one another. Previously, we
had shown significant IFN-c production from CD8+ T cells during
acute infection in response to specific B. melitensis epitopes [16].
IFN-c expression of CD8+ T cells from BALB/c mice chronically
infected with B. melitensis was low at 60 and 180 days post-infection
(Fig. 6). Importantly, the cells were unable to respond with IFN-c
production at 270 days post-infection even in the presence of
active infection shown by CFUs and biophotonic imaging (Fig. 2),
as well as the presence of CD8+ T cells with a memory phenotype
(Fig. 4, A, B and C). Infection did have a significant effect (p,0.05)
on reducing IFN-c production when examining CD8+ T cells
(Fig. 6). Also, at 60 and 270 days post-infection, not only were the
percentages of CD8+ T cells expressing IFN-c less than PBS
treated mice (Fig. 6B), but the geometric mean fluorescence of
IFN-c staining cells in infected mice was significantly less than PBS
treated mice (p,0.0002; data not shown), suggesting suppression
or lack of IFN-c production in Brucella infected mice. Whether
suppression of IFN-c continues in an undulating fashion beyond
270 days of infection would be of interest in future studies.
TNF-a expression from CD8+ T cells does not significantly fall
below or exceed background levels at any time assessed by
examining CD8+ T cells as a ratio of splenocytes (Fig. 7A), as a
percent of CD8+ T cells (Fig. 7B), and as a mean or geometric
mean fluorescence intensity of TNF-a expressing cells (data not
shown). Additionally, CD8+ T cell IL-2 expression was never
significantly above background during this chronic period of
infection (Fig. 8) when examined as a ratio of splenocytes to CD8+
Figure 4. Phenotyping CD8+ Tmem. A) Representative flow cytometric gating strategy of splenic Tmem, CD8+ LFA1
hiCD127
hiKLRG1
lo at day 60
post-infection. From left to right the panels show gating of CD8+ cells, LFA1
hiCD8+ cells, and CD8+ LFA1
hiCD127
hiKLRG1
lo cells from analysis of
500,000 to 1 million cells. B) Plots showing the absence of Tmem in age-matched uninfected mice (PBS injected) and the presence of Tmem in mice
with chronic brucellosis. C) Frequency of splenic CD8+ Tmem over time. ANOVA was performed to determine if infection with B. melitensis had a
statistically significant impact on the presence of CD8+ Tmem. **p,0.002 for infected animals at the different days except for day 150 where p,0.05.
doi:10.1371/journal.pone.0034925.g004
CTL Evasion, Low Quality CD8+ T Cells
PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e34925T cells (data not shown), as a percent of CD8+ T cells (Fig. 8B),
and as a mean, though IL-2 was significantly lower when
examining the mean fluorescence intensity (p,0.05; data not
shown). These results suggest that while surface markers showed a
memory phenotype, the responding CD8+ T memory cells were of
low quality and not functionally resilient. Additionally, B. melitensis
may not just subvert these immune effectors, but actively suppress
the expression of IFN-c and IL-2 at certain times over the course
of infection.
Discussion
BALB/c mice have long been used as the susceptible model of
brucellosis, yet there remains the uncertainty that Brucella infection
of mice may not be similar to a natural host [6,16,54]. Here, we
present evidence of: 1) chronic infection in BALB/c mice for
greater than 1 year, 2) a low level of CD8+ Tmem cells, 3) lack of
polyfunctional cytokine production, and 4) the B. melitensis protein
TcpB inhibits in vivo cytotoxic CD8+ T killing of Brucella peptide
expressing target cells. BALB/c mice do not clear B. melitensis and
show focal sites of reactivation. The undulating nature of the
bacterial load should not be surprising considering that human
brucellosis has also been known as undulant fever [5]. Histopath-
ological study of the urogenital localization by B. melitensis in
BALB/c mice compared to its prevalence in humans will provide
insight into the local cellular response and environmental cues that
allow such long-term persistence in this location [55].
During brucellosis the function of CD8+ T cells may be
compromised by bacterial factors that contribute to poor
immunological memory. Previous work in our lab had shown
that a protein of B. melitensis, TcpB, binds to PI(4,5)P2 which is
required at the immunological synapse on the target cell side for
effective CD8+ T cell mediated killing [13,23]. We observed that
TcpB treatment of target cells inhibits B. melitensis specific CD8+ T
cell killing, evidence that TcpB represents a novel effector of
adaptive immune evasion. TcpB has also been shown to dampen
NFk-B activation, working as an effector of innate immune
evasion. Also, the Brucella NV9 (NGSSSMATV) and RL9
(RYCINSASL) peptides that are recognized by the cytotoxic
CD8+ T cell are naturally processed from intact Brucella in a
mouse infection [16] supporting the relevant role of the CD8+ T
cells in the present study.
An important concept that has not been addressed in Brucella
research, is the effector to memory transition of effector CD8+ T
cells. Maximizing the number of effectors that make this transition
may improve long-term immunity to Brucella. Recently, the role of
mammalian target of rapamycin (mTOR) in the effector CD8+ T
cell transition to memory has come to light [27,28]. Also,
treatment of LCMV infected mice post-infection with rapamycin,
an mTOR inhibitor, surprisingly increased the quantity and
quality of LCMV specific CD8+ T cells. This effect was
reproduced in vaccinia virus Ankara vaccinated non-human
primates [27]. The pathogenic protein TcpB of Brucella, can bind
to phosphatidylinositol (4,5) bisphosphate (PI(4,5)P2) and
PI(3,4,5)P3 which are present on the APC side of the immuno-
logical synapse [13,23]. Also, both PI(4,5)P2 and PI(3,4,5)P3 lie
upstream of a pathway of mTOR activation in CD8+ T cells [17].
Figure 5. Cytokine co-expression profile of CD8+ T cells
expressing 3 or 2 cytokines simultaneously. A) Frequency of
polyfunctional splenic CD8+ T cells co-expressing IFN-c, TNF-a, and IL-2.
Expression of 3 cytokines from infected animals was not different from
PBS animals over the time of infection, p#0.06 at 180 days. B)
Frequency of dual-function CD8+ T cells co-expressing IFN-c and TNF-
a,p #0.7 on any day. C) Frequency of dual-function CD8+ T cells co-
expressing IFN-c and IL-2, p#0.8 on any day.
doi:10.1371/journal.pone.0034925.g005
CTL Evasion, Low Quality CD8+ T Cells
PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e34925TcpB has a membrane translocation domain and may traffic
between infected and uninfected cells [14]. Fig. 9 shows our
hypotheses related to the action of TcpB and adaptive immunity.
B. melitensis produces TcpB that contains a membrane transloca-
tion domain that permits its movement from the Brucella
containing vesicle to the cytosol of the infected cell [14]. TcpB
binds to PI(4,5)P2 either blocking its action or sequestering
PI(4,5)P2 away from the APC side of the immunological synapse
leading to the failure of CTL lysis of cells expressing Brucella
peptides in the context of MHCI [23]. Also, the membrane
translocation domain of TcpB would allow trafficking of TcpB to
responding CD8+ T cells where it could disrupt FoxO and/or
mTOR decreasing the transition of effector CD8+ T cells to
memory T cells [17]. The resulting decline in functional CD8+ T
memory cells is similar to our current findings. The level of TcpB
expressed in vivo, whether TcpB is actively secreted, or if it
becomes free in the cell after bacterial death are unknown.
Additionally, determining if TcpB is disrupting, activating, or
otherwise manipulating the mTOR activation signaling pathway
may elucidate a mechanism behind the lack of protective memory
seen in many Brucella species/host interactions.
The importance of inducing cellular immunity to intracellular
pathogens is well established [56,57,58,59,60,61]. A successful
vaccine must elicit high quality immunological memory. Murine
brucellosis is markedly exacerbated in b2-microglobulin knockout
mice that lack CD8+ T cells compared to CD4+ T cell deficient
mice or C57BL/6 (wild type) mice, illustrating the predominant
role of MHC class I-restricted T cells in controlling Brucella
infection [62]. Additionally, recent work continues the dissection
of the cytokine and CD8+ T cell component of the host response
to Brucella infection [63]. This is indicative of the importance of
cytotoxic CD8+ T cells in a protective immune response against
Figure 6. CD8+ T cell IFN-c expression. A) Histograms of IFN-c staining over time. Note the top row shows the total IFN-c expression while the
bottom row examines the subtle differences of IFN-c
hi expression between uninfected and infected mice. The black line represents splenocytes from
infected mouse pulsed with B. melitensis specific peptide. The shaded grey region represents splenocytes from an uninfected age-matched mouse
pulsed with B. melitensis specific peptide. B) Percent of CD8+ T cells expressing IFN-c in infected and non-infected mice. *p,0.05.
doi:10.1371/journal.pone.0034925.g006
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candidates, but minimal attempts to characterize CD8+ Tmem that
would be required to engender protection against brucellosis.
Determining CD8+ Tmem presence and quality during chronic
infection was undertaken to enable a needed measure of vaccine
efficacy in future studies. Evaluating CD8+ Tmem when different
Brucella strains and species are compared would provide insight
into virulence and persistence of such strains and species. Future
work will also address the adoptive transfer of memory and
challenge experiments to further define the correlates of protective
immunity.
IFN-c is the cytokine best characterized for its involvement in
brucellosis [64,65,66,67]. A deficiency of IFN-c enhances the
susceptibility of mice to Brucella infection and animals die at
,10 weeks of infection [65]. Also, DNA immunization with a
Brucella gene produced high IFN-c production but no protection
and heat-killed Brucella sp. induce IFN-c and IL-2 but not
protective cytotoxic T cells [68,69]. Here, we focus on the role that
IFN-c has as a measure of quality in CD8+ Tmem. Multifunctional
cells, those expressing IFN-c, TNF-a, and IL-2 simultaneously, are
of central importance in the generation of durable protective
CD8+ T cell memory. Experiments done with Mycobacterium
tuberculosis and the Mycobacterium bovis BCG vaccine have shown an
increase in the quality of the T cell mediated response to challenge
when polyfunctional cells are present [70].
In Fig. 10, we introduce a model of CD8+ T cell functionality
over the course of chronic reactivating brucellosis. The level of
exhausted CD8+ T cells is based on our present cytokine findings
that CD8+ T cells express only a single cytokine (IFNc) and not
additionally important cytokines like TNFa or IL-2 similar to
exhausted CD8+ T cells. Similar exhaustion of cytokine
production by CD8+ T cells is reported for other pathogens
[17,52,53,71,72,73]. Determining additional cell surface markers
as well as transcription factor expression of the CD8+ T memory
cells would further define this CD8+ T cell phenotype. Exhausted
T cells tend to show a surface phenotype similar to effector T cells,
including CD43
hi, CD69
hi, CD62L
lo, CD127
lo, and inhibitory
receptors [71,72,73,74,75,76,77]. Inhibitory receptors PD-1 and
LAG-3 have recently become important targets of research, for
example blocking the PD-1/PD-1L inhibitory pathway can boost
Figure 7. CD8+ T cell TNF-a expression. A) Histograms of TNF-a staining over time. Note the top row shows the total TNF-a expression while the
bottom row examines the subtle differences of TNF-a
hi expression between uninfected and infected mice. The black line represents splenocytes
from infected mouse pulsed with B. melitensis specific peptide. The shaded grey region represents splenocytes from an uninfected age-matched
mouse pulsed with B. melitensis specific peptide. B) Percent of CD8+ T cells expressing TNF-a in infected and non-infected mice.
doi:10.1371/journal.pone.0034925.g007
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conversely, it may be required for a multifunctional protective
response to Salmonella [35,40]. This highlights the importance of
dissecting the intricacies of pathogen specific cellular responses.
Future brucellosis vaccines will need to maximize high quality T
cells that avoid excessive contraction after acute infection and
avoid functional exhaustion during the chronic phase in order to
induce protective memory. We show that chronic infection of
BALB/c with virulent, live Brucella melitensis does not establish
durable, high quality CD8+ T cell memory. CD8+ T cells
responding to long-term infection produce primarily IFN-c in an
undulating pattern that temporally follows the level of bacterial
load (Fig. 10). The lack of significant TNF-a expression has
ramifications on the function and production of IFN-c against
active infection, which has been documented previously [78,79].
IL-2 regulates granzyme expression and is important for the
expansion of CD8+ T cells; therefore, minimal IL-2 expression
would not favor CD8+ T cells responding to reactivation of
senescent brucellosis. Endogenous IL-2 is also intimately involved
in CD8+ T cell survival and proliferation, and considered a critical
aspect of CD8+ T cell mediated protection [80,81]. This work
supports previous studies that have found reduced Th1 immunity
in aged mice and humans suffering from brucellosis [82,83].
Unlike the previous study in aged mice, young mice were infected
in the present study and followed for greater than 1 year. Infected
young mice have a robust immune system and, in theory, should
be able to clear infection. However, such young mice did not clear
the bacteria supporting the ongoing chronic nature of brucellosis.
Also, during acute murine brucellosis antigen presenting cells
could process intact Brucella and present the NV9 peptide to CD8+
T cells generating a robust cytotoxic T cell response [16];
however, in the presence of the Brucella TcpB protein cytotoxicity
is inhibited and as infection progressed cytokine production by
CD8+ T cells is reduced.
The findings presented here contribute to understanding the
host immunologic response during chronic B. melitensis infection.
The fact that biophotonic imaging demonstrates BALB/c mice do
not clear B. melitensis has importance in vaccine and challenge
studies. If Brucella cannot be cultured from spleens, that does not
confirm the mouse is uninfected or has cleared infection. In
chronic brucellosis of BALB/c mice the clitoral gland appears to
be a site of frequent long-term infection and humans frequently
have focal infection of the genital tract [55]. The tropism for
the genital organs of ruminants may be related to the high
Figure 8. CD8+ T cell IL-2 expression. A) Histograms of IL-2 staining over time. Note the top row shows the total IL-2 expression while the
bottom row examines the subtle differences of IL-2 expression between uninfected and infected mice. The black line represents splenocytes from
infected mouse pulsed with B. melitensis specific peptide. The shaded grey region represents splenocytes from an uninfected age-matched mouse
pulsed with B. melitensis specific peptide. B) Percent of CD8+ T cells expressing IL-2 in infected and non-infected mice.
doi:10.1371/journal.pone.0034925.g008
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allows Brucella to grow. Although in humans the concentration of
erythritol in seminal fluid and prostatic secretions is far lower than
that found in ruminants, there are high concentrations of other
carbohydrates, which might explain the fact that genitourinary
complications are also frequent in humans. Although CD8+ Tmem
that are CD127+KLRG1
lo are present long after initial infection,
the cytokine response by these cells is weak suggesting an
exhaustive phenotype of CD8+ Tmem that may contribute to
continuing, chronic Brucella infection. Future work will investigate
the role of TcpB in evasion of multiple layers of immunity and
how this protein affects the lack of strong memory response.
Materials and Methods
Brucella melitensis
Bioluminescent B. melitensis GR023 [84] was grown in brucella
broth (Difco) at 37uC with shakig.
Immunization of Mice
Female BALB/c mice (6–8 weeks of age) were obtained from
Harlan (Indianapolis, IN) and housed in AAALAC approved
facilities under pathogen-free conditions using protocols approved
by the university animal care committee (number V0554). For in
vivo killing studies, groups of 4 mice were immunized s.c. at the
base of the tail with 50 mg of each peptide in PBS/10% DMSO
emulsified 1:1 in IFA, or IFA alone. For the Brucella specific
immunological memory studies, groups of 4 mice were immunized
intraperitoneal (i.p.) with 10
7 B. melitensis GR023 [84] to ensure
establishing long-term infection without causing death. Uninfected
age-matched mice were injected i.p. with phosphate buffered
saline (PBS) in the place of bacteria. This study was carried out in
strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of
Health. The protocol was approved by the Institutional Animal
Care and Use Committee of the University of Wisconsin-Madison
that evaluates the ethics of animal experiments (Permit Number:
V00554). All in vivo imaging was performed under isofluorane gas
anesthesia. All efforts were made to minimize animal suffering,
and animals were housed in AAALAC accredited facilities.
In vivo imaging
Mice were evaluated using biophotonic imaging as previously
described [84,85]. Briefly, mice were anaesthetized per AAALAC
and institutional guidelines for a ten minute exposure in the IVIS
Imaging System (Caliper LifeSciences, Hopkinton, MA). Images
were collected and analyzed using Living Image (Caliper Life-
Sciences, Hopkinton, MA).
Surface staining and flow cytometry
Splenocytes from immunized and control mice were isolated
and immediately stained with anti-CD8 (PerCP-Cy, Beckman
Coulter, Fullerton, CA), anti-CD3, anti-LFA1 (a.k.a. CD11a),
anti-CD127 (17A2, 2D7, and SB/199, BD Biosciences, San Jose,
CA), and anti-KLRG1 (2F1, Abcam, Cambridge, MA). Flow
cytometry was performed on an FC500 (Beckman Coulter,
Figure 9. Model of TcpB disruption of adaptive immune response during brucellosis. T = TcpB; BCV = Brucella containing vacuole; ER
= endoplasmic reticulum. TcpB can inhibit CD8+ T cell specific killing of B. melitensis specific target cells. We hypothesize that this inhibition results
from the binding of TcpB to PI(4,5)P2 and either blocking its action or sequestering it away from the APC side of the immunological synapse. Also,
TcpB contains a membrane translocation domain that may allow it to travel into the responding CD8+ T cell. We hypothesize that TcpB binding of
PI(4,5)P2 and PI(3,4,5)P3, TcpB is disrupting by either up-regulating or down-regulating the action of FoxO and/or mTOR. We hypothesize that this
disruption leads to decreased numbers of CD8+ T cell making the effector to memory transition necessary for protective immunity. IL-2 and IL-12
activate PI3K which phosphorylates PI(4,5)P2 into PI(3,4,5)P3. This triggers activation of PKB by PDK1, which can then phosphorylate FoxO and lead to
its degradation, and PKB can activate mTOR complex 1. mTORC1 can then up-regulate T-bet, down-regulate Eomes, activate Klf2, and possibly
activate FoxO. These actions regulate the fate (short-lived effector or long-lived memory) of the responding CD8+ T cell. Rapamycin and metformin
target mTOR and AMPK respectively leading to modulation of memory cell development. Adapted from [17].
doi:10.1371/journal.pone.0034925.g009
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6 events acquired. Data was
further analyzed using FlowJo (Tree Star, Ashland, OR) and Prism
(GraphPad Software, La Jolla, CA).
Intracellular cytokine assay
Splenocytes from immunized and control mice were cultured in
96-well round bottom plates (1610
6 cells/well) in complete
medium in the presence of 100 mg/ml–0.1 ng/ml of purified
MHC Class I peptide (.90% purity, GenScript, Piscataway, NJ),
10 mg/ml GolgiPlug (BD Biosciences, San Jose, CA), with or
without Concanavalin A (Sigma-Aldrich, St. Louis, MO). After
5 hrs, cells were surface stained with anti-CD8 and anti-CD3.
Cells were treated with Lysis Buffer (BD Biosciences, San Jose,
CA) then fixed and permeabilized according to the Cytofix/
Cytoperm manufacturers protocol, with a subsequent intracellular
stain with anti-IFNc, anti-TNFa, and anti-IL-2 (BD Biosciences,
San Jose, CA). Flow cytometry was performed on an FC500
(Beckman Coulter, Fullerton, CA). Data was further analyzed
using FlowJo (Tree Star, Ashland, OR) and Prism (GraphPad
Software, La Jolla, CA).
Protein purification
Expression and purification of TcpB was performed as
previously described [14]. Briefly, Overnight grown E. coli BL21
cells harboring the pMALTcpB plasmid construct or pMAL
vector was inoculated (0.1%) into 1L of LB medium with glucose
(2 g) and ampicillin (100 mg/mL). The culture was grown at 37uC
and induced with IPTG to a final concentration of 0.5 mM when
the OD600 reached 0.6. The induced culture was then grown at
25uC for 5 hrs. Cells were collected by centrifugation and
resuspended in sonication buffer containing 50 mM Tris-HCI
[pH 8.0], 1 M NaCI, 1 mM EDTA and 1X protease inhibitor
cocktail (Pierce). Cells were sonicated and then centrifuged at
160006g for 20 min to clarify the supernatant. The supernatant
was passed through a column harboring 5 mL of amylose resin
(NEB). The column was then washed with the sonication buffer
followed by the same buffer containing decreasing concentrations
of NaCI (750, 500, 250 and 100 mM). The bound MBP-TcpB
protein was eluted with an elution buffer containing 50 mM Tris-
HCI [pH 8.0] and 30 mM maltose. The eluted protein was then
subjected to Genenase I protease site to cleave TcpB from MBP
followed by SP Sepharose (Sigma) ion exchange chromatography
to remove maltose followed by concentration using a centricon
protein concentrator (Millipore). The concentrated protein was
dialyzed in a buffer containing 50 mM Tris-HCI, 100 mM NaCI
and 10 % glycerol and stored at 280uC as aliquots. MBP was used
as a negative control.
In vivo killing assay
Splenocytes from naive BALB/c mice were cultured overnight
with 50 mg/ml of purified TcpB or MBP as a negative control. As
described previously [16,47], control and experimental splenocytes
were then labeled with 5.0 mm or 0.5 mm CFSE (high and low
concentrations, respectively). CFSE
lo cells were pulsed with
irrelevant peptide, GYKVAPAAL, (1 mg/ml) and CFSE
hi cells
were pulsed with NGSSSMATV (1 mg/ml) for 2 hrs prior to
CFSE staining. Equal amounts of CFSE
hi and CFSE
lo cells were
combined and transferred (,1610
7 total cells/mouse) via retro-
orbital injection to anaesthetized syngeneic mice that had been
peptide immunized 7 days prior. After 6 hrs, splenocytes were
analyzed by flow cytometry for the presence of hi and lo CFSE-
labeled cells. The percent killing was calculated as (1-(Ratio of
Irrelevant:Epitope specific cells in naı ¨ve mouse/Ratio in immu-
nized mouse)) 6100 [86].
Statistical analysis
To determine statistical significance, paired Student’s t-test and
ANOVA were performed on the data against the control using
Prism (GraphPad Software, La Jolla, CA). A p value of ,0.05 was
considered significant.
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Figure 10. Models of CD8+ T cell function during chronic
reactivating brucellosis. A) Model of CD8+ T cell functional response
during chronic infection with Brucella melitensis. Initially, CD8+ T cells
respond to B. melitensis and clonally expand with many clones
producing one cytokine such as IFNc, while fewer clones produce
two or three cytokines. With continuing waves of Brucella release from
infected cells, CD8+ T cell expansion is reduced with fewer and fewer
cells producing multiple cytokines and a larger pool of cells producing
no detectable cytokines representing an exhausted phenotype.
Adapted from [87]. B) Model of CD8+ T cell expression of individual
cytokines. Black dotted line represents background level of expression
in uninfected mice. As waves of Brucella are released from infected cells,
cytokine expression occurs with reduction of IFNc and no IL-2 or TNFa
expression.
doi:10.1371/journal.pone.0034925.g010
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